Schneider et al., 1997 - Google Patents
Atopic disease, rhinitis and conjunctivitis, and upper respiratory infectionsSchneider et al., 1997
- Document ID
- 13887393667743233641
- Author
- Schneider L
- Lester M
- Publication year
- Publication venue
- Current Opinion in Pediatrics
External Links
Snippet
This review highlights recent information on the topics of atopic diseases and upper respiratory infections. Recent findings on the costs and therapies of atopic dermatitis are discussed. New insights into egg allergy, peanut allergy, food-induced exercise …
- 206010046306 Upper respiratory tract infection 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12016917B2 (en) | Peanut formulations and uses thereof | |
| James et al. | Respiratory reactions provoked by double-blind food challenges in children. | |
| Hirsch et al. | Double‐blind placebo‐controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children | |
| Bodtger et al. | The safety and efficacy of subcutaneous birch pollen immunotherapy-a one-year, randomised, double-blind, placebo-controlled study | |
| Christian Virchow Jr et al. | Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids | |
| Durham et al. | Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis | |
| Niu et al. | Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan | |
| Taramarcaz et al. | The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome | |
| EP2796142B1 (en) | Pharmaceutical composition comprising dead cells of lactobacillus acidophilus lb strain for treating or preventing allergic disease | |
| Tarlo et al. | Papain‐induced allergic reactions | |
| Kooi et al. | Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial | |
| Ollier et al. | The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing | |
| Iordache et al. | A review regarding the connections between allergic rhinitis and asthma-epidemiology, diagnosis and treatment | |
| Marcucci et al. | Low‐dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides | |
| Zou et al. | Effectiveness and safety of Sanhan Huashi granules versus nirmatrelvir–ritonavir in adult patients with COVID-19: a randomized, open-label, multicenter trial | |
| Silverman et al. | Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis | |
| Schneider et al. | Atopic disease, rhinitis and conjunctivitis, and upper respiratory infections | |
| Anderson et al. | Dust mite–induced perennial allergic rhinitis in pediatric patients and sublingual immunotherapy | |
| Suresh | Epidemiology & management of cough in smaller settings–An Indian case study | |
| TW581675B (en) | A pharmaceutical composition for use in preventing the onset of asthma in a patient | |
| Yang | Asthma management issues in infancy and childhood | |
| Awasthi et al. | Pediatric Allergic Disorders and their Management | |
| Endaryanto et al. | Role of sublingual immunotherapy and probiotics in clinical improvements of childhood asthma | |
| Del Giudice et al. | Allergic rhinitis | |
| Kashyap et al. | Dermatological Manifestation of Food Allergies and Sensitivities |